Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Survanta for obstructive sleep apnea in women with primary Sjogren's syndrome
ACTRN12612000113853Phase 2Completed
- Sponsor
- Adelaide Institute for Sleep Health
- Start
- Apr 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of beractant in obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by Adelaide Institute for Sleep Health. Primary endpoint: Apnea Hypopnea Index. Started Apr 2011; status: completed.
02
Drugs
beractant
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12612000113853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000113853.